The Valley Desk

NCT00031083 · Interventional trial

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Overall registry status Completed

Phase 1

Conditions Anaplastic Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, Oligoastrocytoma, Mixed

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov